homoorientin has been researched along with Acute Confusional Senile Dementia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, QX; Sun, X; Tan, X; Wei, J; Wu, Z; Zhang, Z | 1 |
| Kim, B; Lee, KY; Park, B | 1 |
| Bai, S; Dong, Y; Forest, KH; Li, QX; Li, Y; Liang, Z; Nichols, RA; Tan, X; Yi, L; Zhi, Y | 1 |
| Ali, MY; Choi, JS; Islam, MN; Jung, HA; Kim, YM; Park, HJ; Sohn, HS | 1 |
4 other study(ies) available for homoorientin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Gastrointestinal Microbiome; Luteolin; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Presenilin-1 | 2022 |
Isoorientin Inhibits Amyloid β
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Line; Inflammation; Luteolin; Mice; Microglia; NF-kappa B; Peptide Fragments; Signal Transduction | 2021 |
Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Glycogen Synthase Kinase 3 beta; Inflammation; Luteolin; Male; Memory Disorders; Mice; Mice, Transgenic; Microglia; Neuroprotective Agents; Phosphorylation; Presenilin-1; Protein Kinase Inhibitors; Spatial Memory; tau Proteins | 2021 |
The effects of C-glycosylation of luteolin on its antioxidant, anti-Alzheimer's disease, anti-diabetic, and anti-inflammatory activities.
Topics: Aldehyde Reductase; Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Anti-Inflammatory Agents; Antioxidants; Aspartic Acid Endopeptidases; Biphenyl Compounds; Cell Survival; Cells, Cultured; Cholinesterase Inhibitors; Cyclooxygenase 2 Inhibitors; Flavonoids; Glucosides; Glycosylation; Hypoglycemic Agents; In Vitro Techniques; Luteolin; Nitric Oxide; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Picrates; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rats; Reactive Oxygen Species; Structure-Activity Relationship | 2014 |